Registration Rights Agreement


 Exhibit 4.4 
 EXECUTION VERSION 
 REGISTRATION RIGHTS AGREEMENT 

by and among 

LyondellBasell Industries N.V. 
 the Guarantors 
 party hereto 

and 
 J.P.
Morgan Securities LLC 
 and the other Initial Purchasers 

Dated as of April 9, 2012 






 REGISTRATION RIGHTS AGREEMENT 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 9, 2012, by and among
LyondellBasell Industries N.V., a public company with limited liability (naamloze vennootschap) in the country of The Netherlands (the “Company”), the Guarantors (as defined in the Purchase Agreement (as defined below)) and J.P.
Morgan Securities LLC, as representative of the several initial purchasers listed in Schedule A to the Purchase Agreement (collectively, the “Initial Purchasers”), each of whom has agreed to purchase a portion of the $2,000,000,000
aggregate principal amount of the Company’s 5.000% Senior Notes due 2019 (the “2019 Notes”) and a portion of the $1,000,000,000 aggregate principal amount of the Company’s 5.750% Senior Notes due 2024 (the “2024 Notes”
and, together with the 2019 Notes, the “Initial Notes”), each of which are fully and unconditionally guaranteed by the Guarantors (the “Guarantees”) pursuant to the Purchase Agreement. The Initial Notes and the related Guarantees
are herein collectively referred to as the “Securities.” 
 This Agreement is made pursuant to the Purchase Agreement,
dated March 26, 2012 (the “Purchase Agreement”), among the Company, the Guarantors and the Initial Purchasers (i) for the benefit of the Initial Purchasers and (ii) for the benefit of the holders from time to time of the
Securities, including the Initial Purchasers. In order to induce the Initial Purchasers to purchase the Securities, the Company has agreed to provide the registration rights set forth in this Agreement. The execution and delivery of this Agreement
is a condition to the obligations of the Initial Purchasers set forth in Section 5(h) of the Purchase Agreement. 
 The
parties hereby agree as follows: 
 SECTION 1. Definitions. As used in this Agreement, the following capitalized terms
shall have the following meanings: 
 Additional Interest Payment Date: With respect to the Securities of each
series, each Interest Payment Date. 
 Broker-Dealer: Any broker or dealer registered under the Exchange Act.

 Business Day: Any day other than a Saturday, Sunday or other day on which banking institutions or trust
companies are authorized or required by law to close in New York City, London or The Netherlands. 
 Commission:
The United States Securities and Exchange Commission. 
 Consummate: A registered Exchange Offer with respect to a series
of Securities shall be deemed “Consummated” for purposes of this Agreement upon the occurrence of (i) the filing and effectiveness under the Securities Act of the Exchange Offer Registration Statement relating to the Exchange
Securities to be issued in the Exchange Offer with respect to such series, (ii) the maintenance of such Registration Statement continuously effective and the keeping of such Exchange Offer open for a period not less than the minimum period
required pursuant to Section 3(b) hereof, and (iii) the delivery by the Company to the Registrar under the Indenture of Exchange Securities in the same aggregate principal amount and of the same series as the aggregate principal amount of
Securities of such series that were tendered by Holders thereof pursuant to the Exchange Offer. 
 Effectiveness Target
Date: A date no later than 365 days after the Issue Date or if such 365th day is not a Business Day, the next succeeding Business Day. 
 Exchange Act: The Securities Exchange Act of 1934, as amended. 

Exchange Date: As defined in Section 3(b) hereof. 

Exchange Offer: The registration by the Company under the Securities Act of a series of Exchange Securities pursuant to a
Registration Statement pursuant to which the Company offers the Holders of all outstanding Transfer Restricted Securities of such series the opportunity to exchange all such outstanding Transfer Restricted Securities of such series held by such
Holders for Exchange Securities of the same series in an aggregate principal amount equal to the aggregate principal amount of the Transfer Restricted Securities of the such series tendered in such exchange offer by such Holders. 

  
 2 







 Exchange Offer Registration Statement: A Registration Statement relating to an
Exchange Offer, including the related Prospectus. 
 Exempt Resales: The transactions in which the Initial
Purchasers propose to sell the Securities to certain “qualified institutional buyers,” as such term is defined in Rule 144A under the Securities Act, to certain institutional “accredited investors,” as such term is defined in
Rule 501(a)(1), (2), (3) and (7) of Regulation D under the Securities Act, and to certain non-U.S. persons pursuant to Regulation S under the Securities Act. 
 Exchange Securities: The 5.000% Senior Notes due 2019 and the 5.750% Senior Notes due 2024, and the related Guarantees, to be issued to Holders in exchange for Transfer Restricted Securities of the
applicable series pursuant to this Agreement. 
 FINRA: The Financial Industry Regulatory Authority, Inc. 

Guarantees: As defined in the preamble hereto. 
 Guarantors: As defined in the preamble hereto. 

Holders: As defined in Section 2(b) hereof. 
 Indemnified Holder: As defined in Section 8(a) hereof. 

Indenture: The Indenture, dated as of April 9, 2012, by and among the Company, the Guarantors and Wells Fargo Bank, National
Association, as trustee (the “Trustee”), pursuant to which the Securities are to be issued, as such Indenture is amended or supplemented from time to time in accordance with the terms thereof. 

Initial Purchasers: As defined in the preamble hereto. 

Initial Notes: As defined in the preamble hereto. 
 Initial Placement: The issuance and sale by the Company of the Securities to the Initial Purchasers pursuant to the Purchase Agreement. 

Interest Payment Date: As defined in the Indenture and the applicable Securities. 

Issue Date: April 9, 2012. 
 Person: An individual, partnership, corporation, trust or unincorporated organization, or a government or agency or political subdivision thereof. 

Prospectus: The prospectus included in a Registration Statement, as amended or supplemented by any prospectus supplement and by
all other amendments thereto, including post-effective amendments, and all material incorporated by reference into such Prospectus. 
 Purchase Agreement: As defined in the preamble hereto. 

Registration Default: As defined in Section 5 hereof. 

Registration Statement: Any registration statement of the Company relating to (a) an offering of Exchange Securities
pursuant to an Exchange Offer or (b) the registration for resale of Transfer Restricted Securities pursuant to a Shelf Registration Statement, which is filed pursuant to the provisions of this Agreement, in each case, including the Prospectus
included therein, all amendments and supplements thereto (including post-effective amendments) and all exhibits and material incorporated by reference therein. 
 Securities: As defined in the preamble hereto. 
 Securities
Act: The Securities Act of 1933, as amended. 

  
 3 







 Shelf Filing Deadline: As defined in Section 4(a) hereof. 

Shelf Registration Statement: As defined in Section 4(a) hereof. 

Transfer Restricted Securities: Each Security, until the earliest to occur of (a) the date on which such Security is
exchanged in an Exchange Offer for an Exchange Security of the same series entitled to be resold to the public by the Holder thereof without complying with the prospectus delivery requirements of the Securities Act, (b) the date on which such
Security has been effectively registered under the Securities Act and disposed of in accordance with a Shelf Registration Statement and (c) the date on which such Security is distributed to the public by a Broker-Dealer pursuant to the
“Plan of Distribution” contemplated by the Exchange Offer Registration Statement (including delivery of the Prospectus contained therein). 
 Trust Indenture Act: The Trust Indenture Act of 1939, as amended. 

Underwritten Registration or Underwritten Offering: A registration in which securities of the Company are sold to an underwriter
for reoffering to the public. 
 SECTION 2. Securities Subject to this Agreement. 

(a) Transfer Restricted Securities. The securities entitled to the benefits of this Agreement are the Transfer
Restricted Securities. 
 (b) Holders of Transfer Restricted Securities. A Person is deemed to be a holder of
Transfer Restricted Securities (each, a “Holder”) whenever such Person owns Transfer Restricted Securities. 
 SECTION
3. Registered Exchange Offer. 
 (a) With respect to each series of Securities, unless an Exchange Offer with respect to
such series shall not be permissible under applicable law or Commission policy (after the procedures set forth in Section 6(a) hereof have been complied with), or there are no Transfer Restricted Securities of such series outstanding, each of
the Company and the Guarantors shall (i) use its commercially reasonable efforts to cause to be filed with the Commission as soon as reasonably practicable, but in any event no later than the Effectiveness Target Date, a Registration Statement
under the Securities Act relating to the Exchange Securities and the Exchange Offer for such series, (ii) use its commercially reasonable efforts to cause such Registration Statement to become effective as soon as reasonably practicable but in
any event no later than the Effectiveness Target Date, (iii) in connection with the foregoing, file (A) all pre-effective amendments to such Registration Statement as may be necessary in order to cause such Registration Statement to become
effective, (B) if applicable, a post-effective amendment to such Registration Statement pursuant to Rule 430A under the Securities Act and (C) cause all necessary filings in connection with the registration and qualification of the
Exchange Securities of such series to be made under the state securities or blue sky laws of such jurisdictions as are necessary to permit Consummation of such Exchange Offer, and (iv) upon the effectiveness of such Registration Statement,
commence the Exchange Offer for such series. The Exchange Offer for such series shall be on the appropriate form permitting registration of the Exchange Securities of such series to be offered in exchange for the Transfer Restricted Securities of
the same series and to permit resales of Securities of such series held by Broker-Dealers as contemplated by Section 3(c) hereof. 
 (b) The Company and the Guarantors shall use commercially reasonable efforts to cause the Exchange Offer Registration Statement with respect to such series to be effective continuously and shall keep the
Exchange Offer for such series open for a period of not less than the minimum period required under applicable federal and state securities laws to Consummate such Exchange Offer; provided, however, that in no event shall such period be less than 20
Business Days after the date notice of such Exchange Offer is mailed to the Holders. The Company shall cause the Exchange Offer for such series to comply with all applicable federal and state securities laws with respect to the disposition of all
securities of such series covered by the Exchange Offer. No securities other than the Exchange Securities (of either series) shall be included in an Exchange Offer Registration Statement. The Company shall use its commercially reasonable efforts to
cause the Exchange Offer for such series to be Consummated on the earliest practicable date after the Exchange Offer Registration Statement for such series has become effective, but in no event later than 45 days after the Effectiveness Target Date
(or if such 45th day is not a Business Day, the next succeeding Business Day) (the “Exchange Date”). 

  
 4 







 (c) The Company shall indicate in a “Plan of Distribution” section contained in
the Prospectus forming a part of the Exchange Offer Registration Statement with respect to such series that any Broker-Dealer who holds Securities that are Transfer Restricted Securities of such series and that were acquired for its own account as a
result of market-making activities or other trading activities (other than Transfer Restricted Securities of such series acquired directly from the Company), may exchange such Securities of such series pursuant to the Exchange Offer for such series;
however, such Broker-Dealer may be deemed to be an “underwriter” within the meaning of the Securities Act and must, therefore, deliver a prospectus meeting the requirements of the Securities Act in connection with any resales of the
Exchange Securities received by such Broker-Dealer in such Exchange Offer, which prospectus delivery requirement may be satisfied by the delivery by such Broker-Dealer of the Prospectus contained in the Exchange Offer Registration Statement for such
series. Such “Plan of Distribution” section shall also contain all other information with respect to such resales by Broker-Dealers that the Commission may require in order to permit such resales pursuant thereto, but such “Plan of
Distribution” shall not name any such Broker-Dealer or disclose the amount of Securities held by any such Broker-Dealer except to the extent required by the Commission. 
 Each of the Company and the Guarantors shall use its commercially reasonable efforts to keep the Exchange Offer Registration Statement with respect to such series continuously effective, supplemented and
amended as required by the provisions of Section 6(c) hereof to the extent necessary to ensure that it is available for the resale of Securities of such series acquired by Broker-Dealers for their own accounts as a result of market-making
activities or other trading activities, and to ensure that it conforms with the requirements of this Agreement, the Securities Act and the policies, rules and regulations of the Commission as announced from time to time, for a period ending on the
earlier of (i) 90 days following the consummation of the Exchange Offer for such series exclusive of any period during which any stop order shall be in effect suspending the effectiveness of such Exchange Offer Registration Statement, and
(ii) the date on which a Broker-Dealer is no longer required to deliver a prospectus in connection with market-making or other trading activities. 
 The Company shall provide sufficient copies of the latest version of such Prospectus to Broker-Dealers promptly upon request at any time during such 90 day period (or shorter as provided in the foregoing
sentence) period in order to facilitate such resales. 
 SECTION 4. Shelf Registration. 

(a) Shelf Registration. With respect to each series of Securities, if (i) the Company is not required to file an Exchange
Offer Registration Statement with respect to such series or permitted to effect an Exchange Offer for such series because such Exchange Offer is not permitted by applicable law or Commission policy (after the procedures set forth in
Section 6(a) hereof have been complied with), (ii) for any reason the Exchange Offer for such series is not Consummated prior to the Effective Target Date, (iii) prior to the 20th Business Day following the Exchange Date for such
series, any Initial Purchaser requests from the Company with respect to Transfer Restricted Securities of such series not eligible to be exchanged for Exchange Securities in such Exchange Offer or (iv) prior to the 20th Business Day following
the Exchange Date for such series, with respect to any Holder of Transfer Restricted Securities of such series, such Holder notifies the Company that (A) such Holder is prohibited by applicable law or Commission policy from participating in
such Exchange Offer, or (B) such Holder may not resell the Exchange Securities acquired by it in such Exchange Offer to the public without delivering a prospectus (other than by reason of such Holder’s status as affiliate of the Company)
and that the Prospectus contained in the Exchange Offer Registration Statement is not appropriate or available for such resales by such Holder, or (C) such Holder is a Broker-Dealer and holds Securities of such series acquired directly from the
Company or one of its affiliates, then, upon such Holder’s request, the Company and the Guarantors shall (except for a shelf registration required by clause (ii) above if the Exchange Offer for such series has at the relevant time been
Consummated) 
 (x) cause to be filed a shelf registration statement with respect to such Securities pursuant to
Rule 415 under the Securities Act, which may be an amendment to the Exchange Offer Registration Statement for such series within 45 days after such filing obligation arises (or if such 45th day is not a Business Day, the next succeeding Business
Day) (such date being the “Shelf Filing Deadline”), which Shelf Registration Statement shall provide for resales of all Transfer Restricted Securities of such series the Holders of which shall have provided the information required
pursuant to Section 4(b) hereof; and 

  
 5 







 (y) use their commercially reasonable efforts to cause such Shelf
Registration Statement to be declared effective by the Commission on or before the 90th day after the Shelf Filing Deadline (or if such 90th day is not a Business Day, the next succeeding Business Day) (the “Shelf Effectiveness Date”).

 Each of the Company and the Guarantors shall use its commercially reasonable efforts to keep such Shelf Registration
Statement continuously effective, supplemented and amended as required by the provisions of Sections 6(b) and (c) hereof to the extent necessary to ensure that it is available for the resale of Securities of such series by the Holders of such
Transfer Restricted Securities entitled to the benefit of this Section 4(a), and to ensure that it conforms with the requirements of this Agreement, the Securities Act and the policies, rules and regulations of the Commission as announced from
time to time, for a period ending on the earlier of (i) one-year following the effective date of such Shelf Registration Statement; (ii) the date when all the Securities of such series covered by such Shelf Registration Statement have been
sold pursuant to such Shelf Registration Statement; (iii) the date when all the Securities of such series covered by such Shelf Registration Statement cease to be outstanding; and (iv) the date when all the Securities of such series
covered by such Shelf Registration Statement become eligible for resale pursuant to Rule 144 under the Securities Act without regard to volume, manner of sale or other restrictions contained in Rule 144 (the “Shelf Registration Period”).

 (b) Provision by Holders of Certain Information in Connection with the Shelf Registration Statement. No Holder of
Transfer Restricted Securities with respect to a series may include any of its Transfer Restricted Securities of such series in any Shelf Registration Statement pursuant to this Agreement unless and until such Holder furnishes to the Company in
writing, within 20 Business Days after receipt of a request therefor, such information as the Company may reasonably request for use in connection with any Shelf Registration Statement or Prospectus or preliminary Prospectus included therein. Each
Holder as to which any Shelf Registration Statement of such series is being effected agrees to furnish promptly to the Company all information required to be disclosed in order to make the information previously furnished to the Company by such
Holder not contain an untrue statement of material fact or omit to state any fact necessary to make the statement therein not misleading. 
 SECTION 5. Additional Interest. If (i) an Exchange Offer Registration Statement is required pursuant to Section 3(a) with respect to a series of Securities and such Exchange Offer is not
Consummated within 45 days after the Effectiveness Target Date; or (ii) following the Effectiveness Target Date, a Shelf Registration Statement is required pursuant to Section 4(a)(x) with respect to Securities of such series and such
Shelf Registration Statement (x) is not filed on or prior to the applicable Shelf Filing Deadline, (y) does not become effective on or prior to the 90th day after the Shelf Filing Deadline, or (z) is filed and becomes effective but
thereafter ceases to be effective or the corresponding Prospectus fails to be usable for its intended purpose at any time during the Shelf Registration Period, and such failure to remain effective or usable exists for more than 45 days consecutive
days and up to 120 days in the aggregate, in each case in any 12-month period (each such event referred to in the foregoing clauses (i) or (ii) a “Registration Default”), the Company hereby agrees that the interest rate borne by
the Transfer Restricted Securities of such series shall be increased by 0.25% per annum during the 90-day period immediately following the occurrence of any Registration Default for such series and shall increase by 0.25% per annum at the
end of each subsequent 90-day period, but in no event shall such increase exceed 1.00% per annum. Notwithstanding the foregoing, immediately following the earliest of (x) the cure of all Registration Defaults relating to any particular
Transfer Restricted Securities of such series and (y) the date on which there are no outstanding Transfer Restricted Securities of such series, the interest rate borne by the relevant Transfer Restricted Securities will be reduced to the
original interest rate borne by such Transfer Restricted Securities of such series; provided, however, that, if after any such reduction in interest rate, a different Registration Default for such series occurs, the interest rate borne by the
relevant Transfer Restricted Securities of such series shall again be increased pursuant to the foregoing provisions. 

Notwithstanding the foregoing, (i) the amount of Additional Interest payable in respect of a series of Securities shall not increase
because more than one Registration Default has occurred and is pending in respect of such series and (ii) a Holder of Transfer Restricted Securities that is not entitled to the benefits of the Shelf Registration Statement (because, e.g., such
Holder has not elected to include information or has not timely delivered such information to the Company pursuant to Section 4(b) hereof) shall not be entitled to Additional Interest with respect to a Registration Default for such series that
pertains to the Shelf Registration Statement. 

  
 6 







 All obligations of the Company and the Guarantors set forth in the preceding paragraph that
are outstanding with respect to any Transfer Restricted Security of a series at the time such security ceases to be a Transfer Restricted Security shall survive until such time as all such obligations with respect to such security shall have been
satisfied in full. 
 SECTION 6. Registration Procedures. 

(a) Exchange Offer Registration Statement. In connection with an Exchange Offer with respect to a series, the Company and the
Guarantors shall comply with all of the provisions of Section 6(c) hereof, shall use their commercially reasonable efforts to effect such exchange to permit the sale of Transfer Restricted Securities of such series being sold in accordance with
the intended method or methods of distribution thereof, and shall comply with all of the following provisions: 

(i) If in the reasonable opinion of counsel to the Company there is a question as to whether the Exchange Offer for such
series is permitted by applicable law, each of the Company and the Guarantors hereby agrees to seek a no-action letter or other favorable decision from the Commission allowing the Company and the Guarantors to Consummate an Exchange Offer for such
Securities of such series. Each of the Company and the Guarantors hereby agrees to pursue the issuance of such a decision to the Commission staff level but shall not be required to take commercially unreasonable action to effect a change of
Commission policy. Each of the Company and the Guarantors hereby agrees, however, to (A) participate in telephonic conferences with the Commission, (B) deliver to the Commission staff an analysis prepared by counsel to the Company setting
forth the legal bases, if any, upon which such counsel has concluded that such an Exchange Offer for such series should be permitted and (C) diligently pursue a favorable resolution by the Commission staff of such submission. 

(ii) As a condition to its participation in an Exchange Offer for such series pursuant to the terms of this Agreement,
each Holder of Transfer Restricted Securities of such series shall furnish, upon the request of the Company, prior to the Consummation thereof, a written representation to the Company (which may be contained in the letter of transmittal contemplated
by the Exchange Offer Registration Statement for such series) to the effect that (A) it is not an affiliate of the Company, (B) it is not engaged in, and does not intend to engage in, and has no arrangement or understanding with any Person
to participate in, a distribution of the Exchange Securities of such series to be issued in such Exchange Offer and (C) it is acquiring the Exchange Securities of such series in its ordinary course of business. In addition, all such Holders of
Transfer Restricted Securities of such series shall otherwise cooperate in the Company’s preparations for the Exchange Offer for such series. Each Holder hereby acknowledges and agrees that any Broker-Dealer and any such Holder using the
Exchange Offer of such series to participate in a distribution of the securities to be acquired in such Exchange Offer (1) could not under Commission policy as in effect on the date of this Agreement rely on the position of the Commission
enunciated in Morgan Stanley and Co., Inc. (available June 5, 1991) and Exxon Capital Holdings Corporation (available May 13, 1988), as interpreted in the Commission’s letter to Shearman & Sterling dated July 2, 1993,
and similar no-action letters (which may include any no-action letter obtained pursuant to clause (i) above), and (2) must comply with the registration and prospectus delivery requirements of the Securities Act in connection with a
secondary resale transaction and that such a secondary resale transaction should be covered by an effective registration statement containing the selling security holder information required by Item 507 or 508, as applicable, of Regulation S-K
if the resales are of Exchange Securities of a series obtained by such Holder in exchange for Securities of such series acquired by such Holder directly from the Company. 
 (b) Shelf Registration Statement. In connection with the Shelf Registration Statement with respect to a series, each of the Company and the Guarantors shall comply with all the provisions of
Section 6(c) hereof and shall use its commercially reasonable efforts to effect such registration (unless automatically declared effective) to permit the sale of the Transfer Restricted Securities of such series being sold in accordance with
the intended method or methods of distribution thereof, and pursuant thereto each of the Company and the Guarantors will as soon as commercially reasonable prepare and file with the Commission a Registration Statement relating to the registration on
any appropriate form under the Securities Act, which form shall be available for the sale of the Transfer Restricted Securities of such series in accordance with the intended method or methods of distribution thereof. 

  
 7 







 (c) General Provisions. In connection with any Registration Statement
and any Prospectus required by this Agreement to permit the sale or resale of Transfer Restricted Securities of a series (including, without limitation, any Registration Statement and the related Prospectus required to permit resales of Securities
of such series by Broker-Dealers), each of the Company and the Guarantors shall: 
 (i) use its commercially
reasonable efforts to keep such Registration Statement continuously effective during the period of this Agreement and provide all requisite financial statements (including, if required by the Securities Act or any regulation thereunder, financial
statements of the Guarantors for the period specified in Section 3 or 4 hereof, as applicable); upon the occurrence of any event that would cause any such Registration Statement or the Prospectus contained therein (A) to contain a material
misstatement or omission or (B) not to be effective and usable for resale of Transfer Restricted Securities of such series during the period required by this Agreement, the Company shall file promptly an appropriate amendment to such
Registration Statement, in the case of clause (A), correcting any such misstatement or omission, and, in the case of either clause (A) or (B), use its commercially reasonable efforts to cause such amendment to be declared effective (unless
automatically declared effective) and such Registration Statement and the related Prospectus to become usable for their intended purpose(s) as soon as practicable thereafter; 

(ii) prepare and file with the Commission such amendments and post-effective amendments to the applicable Registration
Statement as may be necessary to keep the Registration Statement effective for the applicable period set forth in Section 3 or 4 hereof, as applicable, or such shorter period as will terminate when all Transfer Restricted Securities of such
series covered by such Registration Statement have been sold; cause the Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 under the Securities Act, and to comply fully with
the applicable provisions of Rules 424 and 430A under the Securities Act in a timely manner; and comply with the provisions of the Securities Act with respect to the disposition of all securities of such series covered by such Registration Statement
during the applicable period in accordance with the intended method or methods of distribution by the sellers thereof set forth in such Registration Statement or supplement to the Prospectus; 

(iii) advise the underwriter(s), if any, and selling Holders promptly and, if requested by such Persons, to confirm such
advice in writing, (A) when the Prospectus or any Prospectus supplement or post-effective amendment has been filed, and, with respect to any Registration Statement or any post-effective amendment thereto, when the same has become effective,
(B) of any request by the Commission for amendments to the Registration Statement or amendments or supplements to the Prospectus or for additional information relating thereto, (C) of the issuance by the Commission of any stop order
suspending the effectiveness of the Registration Statement under the Securities Act or of the suspension by any state securities commission of the qualification of the Transfer Restricted Securities for offering or sale in any jurisdiction, or the
initiation of any proceeding for any of the preceding purposes, (D) of the existence of any fact or the happening of any event that makes any statement of a material fact made in the Registration Statement, the Prospectus, any amendment or
supplement thereto, or any document incorporated by reference therein untrue, or that requires the making of any additions to or changes in the Registration Statement or the Prospectus in order to make the statements therein not misleading. If at
any time the Commission shall issue any stop order suspending the effectiveness of the Registration Statement, or any state securities commission or other regulatory authority shall issue an order suspending the qualification or exemption from
qualification of the Transfer Restricted Securities of such series under state securities or blue sky laws, each of the Company and the Guarantors shall use its commercially reasonable efforts to obtain the withdrawal or lifting of such order at the
earliest possible time; 
 (iv) furnish without charge to each of the Initial Purchasers upon request of a
majority of the Initial Purchasers, each selling Holder named in any Registration Statement, and each of the underwriter(s), if any, before filing with the Commission, copies of any Registration Statement or any Prospectus included therein or any
amendments or supplements to any such Registration Statement or Prospectus (including all documents incorporated by reference after the initial filing of such Registration Statement), which documents will be subject to the review and comment of such
Holders and underwriter(s) in connection with such sale, if any, for a period of at least five Business Days, and the Company will not file any such Registration Statement or Prospectus or any amendment or supplement to any such Registration
Statement or Prospectus (including all such documents incorporated by reference) to which an Initial Purchaser of Transfer Restricted Securities 

  
 8 







 
covered by such Registration Statement or the underwriter(s), if any, shall reasonably object in writing within five Business Days after the receipt thereof (such objection to be deemed timely
made upon confirmation of telecopy transmission within such period). The objection of an Initial Purchaser or underwriter, if any, shall be deemed to be reasonable if such Registration Statement, amendment, Prospectus or supplement, as applicable,
as proposed to be filed, contains a material misstatement or omission. Notwithstanding the last two sentences, the Company shall not be prohibited from making any filing that is, in the opinion of counsel to the Company, necessary to comply with
applicable law; 
 (v) [Reserved.]; 

(vi) make available, subject to customary confidentiality agreements, at reasonable times for inspection by the Initial
Purchasers, the managing underwriter(s), if any, participating in any disposition pursuant to such Registration Statement and any attorney or accountant retained by such Initial Purchasers or any of the underwriter(s), all financial and other
records, pertinent corporate documents and properties of each of the Company and the Guarantors and cause the Company’s and the Guarantors’ officers, directors and employees to supply all information, in each case as shall be reasonably
necessary to enable any such Holder, underwriter, attorney or accountant to exercise any applicable responsibilities in connection with such Registration Statement or any post-effective amendment thereto subsequent to the filing thereof and prior to
its effectiveness and to participate in meetings with investors to the extent requested by the managing underwriter(s), if any; 
 (vii) if requested by any selling Holders or the underwriter(s), if any, promptly incorporate in any Registration Statement or Prospectus, pursuant to a supplement or post-effective amendment if
necessary, such information as such selling Holders and underwriter(s), if any, may reasonably request to have included therein, including, without limitation, information relating to the “Plan of Distribution” of the Transfer Restricted
Securities of such series, information with respect to the principal amount of Transfer Restricted Securities being sold to such underwriter(s), the purchase price being paid therefor and any other terms of the offering of the Transfer Restricted
Securities to be sold in such offering; and make all required filings of such Prospectus supplement or post-effective amendment as soon as practicable after the Company is notified of the matters to be incorporated in such Prospectus supplement or
post-effective amendment; 
 (viii) cause the Transfer Restricted Securities of such series covered by the
Registration Statement to be rated with the appropriate rating agencies, if so requested by the Holders of a majority in aggregate principal amount of Securities of such series covered thereby or the underwriter(s), if any; 

(ix) if requested, furnish to each Initial Purchaser, each selling Holder and each of the underwriter(s), if any, without
charge, at least one copy of the Registration Statement, as first filed with the Commission, and of each amendment thereto, including financial statements and schedules, all documents incorporated by reference therein and all exhibits (including
exhibits incorporated therein by reference); 
 (x) deliver to each selling Holder and each of the
underwriter(s), if any, without charge, as many copies of the Prospectus (including each preliminary prospectus) and any amendment or supplement thereto as such Persons reasonably may request; each of the Company and the Guarantors hereby consents
to the use of the Prospectus and any amendment or supplement thereto by each of the selling Holders and each of the underwriter(s), if any, in connection with the offering and the sale of the Transfer Restricted Securities of such series covered by
the Prospectus or any amendment or supplement thereto; 
 (xi) enter into such agreements (including an
underwriting agreement), and make such representations and warranties, and take all such other commercially reasonable actions in connection therewith in order to expedite or facilitate the disposition of the Transfer Restricted Securities of such
series pursuant to any Registration Statement contemplated by this Agreement, all to such extent as may be reasonably requested by any Initial Purchaser or by any Holder of at least 10% of the aggregate principal amount of Transfer Restricted
Securities of such series then outstanding or underwriter in connection with any sale or resale pursuant to any Registration Statement contemplated by this Agreement; and whether or not an underwriting agreement is entered into and whether or not
the registration is an Underwritten Registration, each of the Company and the Guarantors shall: 

  
 9 







 (A) furnish to each Initial Purchaser, each selling Holder of at least 10%
of the aggregate principal amount of Securities of a series then outstanding and each underwriter, if any, in such substance and scope as they may request and as are customarily made by issuers to underwriters in primary underwritten offerings, upon
the date of the Consummation of an Exchange Offer for such series or, if applicable, the effectiveness of a Shelf Registration Statement for such series: 
 (1) a certificate, dated the date of Consummation of such Exchange Offer or the date of effectiveness of such Shelf Registration Statement, as the case may be, signed by one of the Chief Executive
Officer, Chief Financial Officer, Chief Accounting Officer, Chief Legal Officer or Treasurer of each of the Guarantors, and signed by any member of the Management Board of the Company or any person who has been appointed an attorney or an
attorney-in-fact by resolution of the Management Board of the Company so long as the power of attorney grant by such resolution remains in effect on behalf of the Company, confirming, as of the date thereof, the matters set forth in paragraphs (i),
(ii) and (iii) of Section 5(g) of the Purchase Agreement and such other matters as such parties may reasonably request; 
 (2) if requested by Holders of a majority of the aggregate principal amount of Securities of such series then outstanding, an opinion, dated the date of Consummation of such Exchange Offer or the date of
effectiveness of such Shelf Registration Statement, as the case may be, of counsel for the Company and the Guarantors, covering the matters set forth in the opinions and letter delivered pursuant to Sections 5(c) and 5(d) of the Purchase Agreement
and such other matter as such parties may reasonably request, and in any event including a statement to the effect that such counsel has participated in conferences with officers and other representatives of the Company and the Guarantors,
representatives of the independent public accountants for the Company and the Guarantors, representatives of the underwriter(s), if any, and counsel to the underwriter(s), if any, in connection with the preparation of such Registration Statement and
the related Prospectus and have considered the matters required to be stated therein and the statements contained therein, although such counsel has not independently verified the accuracy, completeness or fairness of such statements; and that such
counsel advises that, on the basis of the foregoing, no facts came to such counsel’s attention that caused such counsel to believe that the applicable Registration Statement, at the time such Registration Statement or any post-effective
amendment thereto became effective, and, in the case of the Exchange Offer Registration Statement for such series, as of the date of Consummation, contained an untrue statement of a material fact or omitted to state a material fact required to be
stated therein or necessary to make the statements therein or that the Prospectus contained in such Registration Statement as of its date and, in the case of the opinion dated the date of Consummation of the Exchange Offer of such series, as of the
date of Consummation, contained an untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which were made, not misleading. Without limiting
the foregoing, such counsel may state further that such counsel assumes no responsibility for, and has not independently verified, the accuracy, completeness or fairness of the financial statements, notes and schedules and other financial data
included in any Registration Statement of such series contemplated by this Agreement or the related Prospectus; and 
 (3) a customary comfort letter, dated the date of effectiveness of the Shelf Registration Statement for such series, from the Company’s independent accountants, in the customary form and covering
matters of the type customarily requested to be covered in comfort letters by underwriters in connection with primary underwritten offerings, and covering or affirming the matters set forth in the comfort letters delivered pursuant to
Section 5(a) of the Purchase Agreement, without exception; 
 (B) set forth in full or incorporate by
reference in the underwriting agreement, if any, the indemnification provisions and procedures of Section 8 hereof with respect to all parties to be indemnified pursuant to said Section; and 

(C) deliver such other documents and certificates as may be reasonably requested by such parties to evidence compliance
with Section 6(c)(xi)(A) hereof and with any customary conditions contained in the underwriting agreement or other agreement entered into by the Company or any of the Guarantors pursuant to this Section 6(c)(xi), if any. 

  
 10 








 If at any time the representations and warranties of the Company and the
Guarantors contemplated in Section 6(c)(xi)(A)(1) hereof cease to be true and correct, the Company or the Guarantors shall so advise the Initial Purchasers and the underwriter(s), if any, and each selling Holder promptly and, if requested by
such Persons, shall confirm such advice in writing; 
 (xii) prior to any public offering of Transfer Restricted
Securities of such series, cooperate with the selling Holders, the underwriter(s), if any, and their respective counsel in connection with the registration and qualification of the Transfer Restricted Securities of such series under the state
securities or blue sky laws of such jurisdictions as the selling Holders or underwriter(s), if any, may request and do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions of the Transfer Restricted
Securities covered by a Shelf Registration Statement for such series; provided, however, that neither the Company nor the Guarantors shall be required to register or qualify as a foreign corporation where it is not then so qualified or to take any
action that would subject it to the service of process in suits or to taxation, other than as to matters and transactions relating to such Registration Statement, in any jurisdiction where it is not then so subject; 

(xiii) shall issue, upon the request of any Holder of Securities of such series covered by the Shelf Registration
Statement for such series, Exchange Securities of such series having an aggregate principal amount equal to the aggregate principal amount of Securities of the same series surrendered to the Company by such Holder in exchange therefor or being sold
by such Holder; such Exchange Securities to be registered in the name of such Holder or in the name of the purchaser(s) of such Securities, as the case may be; in return, the Securities of such series held by such Holder shall be surrendered to the
Company for cancellation; 
 (xiv) cooperate with the selling Holders and the underwriter(s), if any, to
facilitate the timely preparation and delivery of certificates representing Transfer Restricted Securities of such series to be sold and not bearing any restrictive legends; and enable such Transfer Restricted Securities to be in such denominations
and registered in such names as the Holders or the underwriter(s), if any, may request at least two Business Days prior to any sale of such Transfer Restricted Securities made by such Holders or underwriter(s); 

(xv) use its commercially reasonable efforts to cause the Transfer Restricted Securities of such series covered by a
Registration Statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter(s), if any, to consummate the disposition of such Transfer
Restricted Securities, subject to the proviso contained in Section 6(c)(xii) hereof; 
 (xvi) if any fact
or event contemplated by Section 6(c)(iii)(D) hereof shall exist or have occurred, prepare a supplement or post-effective amendment to the Registration Statement or related Prospectus or any document incorporated therein by reference or file
any other required document so that, as thereafter delivered to the purchasers of Transfer Restricted Securities of such series, the Prospectus will not contain an untrue statement of a material fact or omit to state any material fact necessary in
order to make the statements therein not misleading; 
 (xvii) provide a CUSIP number for all Securities of such
series not later than the effective date of the Registration Statement covering such Securities and provide the Trustee under the Indenture with printed certificates for such Securities which are in a form eligible for deposit with the Depository
Trust Company and take all other action necessary to ensure that all such Securities are eligible for deposit with the Depository Trust Company; 
 (xviii) cooperate and assist in any filings required to be made with FINRA and in the performance of any due diligence investigation by any underwriter (including any “qualified independent
underwriter”) that is required to be retained in accordance with the rules and regulations of FINRA; 

(xix) otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the
Commission, and make generally available to its security holders, as soon as practicable, a consolidated 

  
 11 








 
earnings statement meeting the requirements of Rule 158 (which need not be audited) for the twelve-month period (A) commencing at the end of any fiscal quarter in which Transfer Restricted
Securities of such series are sold to underwriters in a firm commitment or best efforts Underwritten Offering or (B) if not sold to underwriters in such an offering, beginning with the first month of the Company’s first fiscal quarter
commencing after the effective date of the Registration Statement for such series; 
 (xx) cause the Indenture
to be qualified under the Trust Indenture Act not later than the effective date of the first Registration Statement for such series required by this Agreement, and, in connection therewith, cooperate with the Trustee and the Holders of Securities of
such series to effect such changes to the Indenture as may be required for such Indenture to be so qualified in accordance with the terms of the Trust Indenture Act; and to execute and use its commercially reasonable efforts to cause the Trustee to
execute, all documents that may be required to effect such changes and all other forms and documents required to be filed with the Commission to enable such Indenture to be so qualified in a timely manner; 

(xxi) cause all Securities of such series covered by the Registration Statement to be listed on each securities exchange
or automated quotation system on which similar securities issued by the Company are then listed if reasonably requested by the Holders of a majority in aggregate principal amount of Securities of such series or the managing underwriter(s), if any;
and 
 (xxii) provide promptly to each Holder upon request each document filed with the Commission pursuant to
the requirements of Section 13 and Section 15 of the Exchange Act. 
 Each Holder agrees by acquisition of a Transfer
Restricted Security of a series that, upon receipt of any notice from the Company of the existence of any fact of the kind described in Section 6(c)(iii)(D) hereof, such Holder will forthwith discontinue disposition of Transfer Restricted
Securities of such series pursuant to the applicable Registration Statement for such series until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 6(c)(xvi) hereof, or until it is
advised in writing (the “Advice”) by the Company that the use of the Prospectus may be resumed, and has received copies of any additional or supplemental filings that are incorporated by reference in the Prospectus. If so directed by the
Company, each Holder will deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus covering such Transfer Restricted Securities that was current at
the time of receipt of such notice. In the event the Company shall give any such notice, the time period regarding the effectiveness of such Registration Statement for such series set forth in Section 3 or 4 hereof, as applicable, shall be
extended by the number of days during the period from and including the date of the giving of such notice pursuant to Section 6(c)(iii)(D) hereof to and including the date when each selling Holder covered by such Registration Statement for such
series shall have received the copies of the supplemented or amended Prospectus contemplated by Section 6(c)(xvi) hereof or shall have received the Advice; provided, however, that no such extension shall be taken into account in determining
whether Additional Interest with respect to such series is due pursuant to Section 5 hereof or the amount of such Additional Interest, it being agreed that the Company’s option to suspend use of a Registration Statement for such series
pursuant to this paragraph shall be treated as a Registration Default for purposes of Section 5 hereof. 
 SECTION 7.
Registration Expenses. 
 (a) All reasonable and documented expenses incident to the Company’s and the Guarantor’s
performance of or compliance with this Agreement will be borne by the Company and the Guarantors, jointly and severally, regardless of whether a Registration Statement becomes effective, including, without limitation: (i) all registration and
filing fees and expenses (including filings made by any Initial Purchaser or Holder with FINRA (and, if applicable, the fees and expenses of any “qualified independent underwriter” and one counsel to such person, that may be required by
the rules and regulations of FINRA)); (ii) all fees and expenses of compliance with federal securities and state securities or blue sky laws; (iii) all expenses of printing (including printing certificates for the Exchange Securities to be
issued in an Exchange Offer and printing of Prospectuses), messenger and delivery services and telephone; (iv) all fees and disbursements of counsel for the Company, the Guarantors and, subject to Section 7(b) hereof, all reasonable fees
and disbursements of one counsel to the Holders of Transfer Restricted Securities of a series; (v) all application and filing fees in connection with listing the Exchange Securities on a securities exchange or automated quotation system
pursuant to the requirements thereof; and (vi) all fees and disbursements of independent certified public accountants of the Company and the Guarantors (including the expenses of any special audit and comfort letters required by or incident to
such performance). 

  
 12 








 Each of the Company and the Guarantors will, in any event, bear its internal expenses
(including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expenses of any annual audit and the fees and expenses of any Person, including special experts, retained by the
Company or the Guarantors. 
 (b) In connection with any Registration Statement required by this Agreement (including, without
limitation, an Exchange Offer Registration Statement and a Shelf Registration Statement), the Company and the Guarantors, jointly and severally, will reimburse the Initial Purchasers and the Holders of Transfer Restricted Securities being tendered
in such Exchange Offer and/or resold pursuant to the “Plan of Distribution” contained in such Exchange Offer Registration Statement or registered pursuant to such Shelf Registration Statement, as applicable, for the reasonable fees and
disbursements of not more than one counsel, who shall be Davis Polk & Wardwell LLP or such other counsel as may be chosen by the Holders of a majority in principal amount of the Transfer Restricted Securities for whose benefit such
Registration Statement is being prepared. 
 SECTION 8. Indemnification. 

(a) The Company and the Guarantors, jointly and severally, agree to indemnify and hold harmless (i) each Holder of a series and
(ii) each Person, if any, who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) any such Holder (any of the Persons referred to in this clause (ii) being hereinafter referred to
as a “controlling person”) and (iii) the respective officers, directors, partners, employees, representatives and agents of any such Holder or any controlling person (any Person referred to in clause (i), (ii) or (iii) may
hereinafter be referred to as an “Indemnified Holder”), to the fullest extent lawful, from and against any and all losses, claims, damages, liabilities, judgments, actions and reasonable expenses, as incurred, (including, without
limitation, and as incurred, reimbursement of all reasonable costs of investigating, preparing, pursuing, settling, compromising, paying or defending any claim or action, or any investigation or proceeding by any governmental agency or body,
commenced or threatened, including the reasonable fees and expenses of counsel to any Indemnified Holder), joint or several, directly or indirectly caused by, related to, based upon, arising out of or in connection with any untrue statement or
alleged untrue statement of a material fact contained in any (x) Registration Statement for such series (or any amendment or supplement thereto), or any omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein or (y) Prospectus for such series (or any amendment or supplement thereto), or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages, liabilities or expenses are caused by an untrue statement or omission or alleged untrue
statement or omission that is made in reliance upon and in conformity with information relating to any of such Holders, its directors, officers, employees or controlling persons furnished in writing to the Company by any of such Holders expressly
for use therein. This indemnity agreement shall be in addition to any liability which the Company or any Guarantor may otherwise have. 
 In case any action or proceeding (including any governmental or regulatory investigation or proceeding) shall be brought or asserted against any of the Indemnified Holders with respect to which indemnity
may be sought against the Company or the Guarantors, such Indemnified Holder (or the Indemnified Holder controlled by such controlling person) shall promptly notify the Company and the Guarantors in writing; provided, however, that the failure to
give such notice shall not relieve any of the Company or the Guarantors of its obligations pursuant to this Agreement. Such Indemnified Holder shall have the right to employ its own counsel in any such action and the fees and expenses of such
counsel shall be paid, as incurred, by the Company and the Guarantors (regardless of whether it is ultimately determined that an Indemnified Holder is not entitled to indemnification hereunder). The Company and the Guarantors shall not, in
connection with any one such action or proceeding or separate but substantially similar or related actions or proceedings in the same jurisdiction arising out of the same general allegations or circumstances, be liable for the reasonable fees and
expenses of more than one separate firm of attorneys (in addition to any local counsel) at any time for such Indemnified Holders, which firm shall be designated by the Holders. The Company and the Guarantors shall be liable for any settlement of any
such action or proceeding effected with the Company’s and the Guarantors’ prior written consent, which consent shall not be withheld 

  
 13 








 
unreasonably, and each of the Company and the Guarantors agree to indemnify and hold harmless any Indemnified Holder from and against any loss, claim, damage, liability or expense by reason of
any settlement of any action effected with the written consent of the Company and the Guarantors. The Company and the Guarantors shall not, without the prior written consent of each Indemnified Holder, settle or compromise or consent to the entry of
judgment in or otherwise seek to terminate any pending or threatened action, claim, litigation or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not any Indemnified Holder is a party thereto),
unless such settlement, compromise, consent or termination (i) includes an unconditional release of each Indemnified Holder from all liability arising out of such action, claim, litigation or proceeding and (ii) does not include any
statements as to or any findings of fault, culpability or failure to act by or on behalf of any indemnified party. 
 (b) Each
Holder of Transfer Restricted Securities of a series agrees, severally and not jointly, to indemnify and hold harmless the Company, the Guarantors and their respective directors, officers of the Company and the Guarantors who sign a Registration
Statement for such series, and any Person controlling (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) the Company or any of the Guarantors, and the respective officers, directors, partners,
employees, representatives and agents of the Company, the Guarantors and any such Person, to the same extent as the foregoing indemnity from the Company and the Guarantors to each of the Indemnified Holders, but only with respect to claims and
actions based on information relating to such Holder furnished in writing by such Holder expressly for use in any Registration Statement for such series. In case any action or proceeding shall be brought against the Company, the Guarantors or their
respective directors or officers or any such controlling person in respect of which indemnity may be sought against a Holder of Transfer Restricted Securities of such series, such Holder shall have the rights and duties given the Company and the
Guarantors, and the Company, the Guarantors, their respective directors and officers and such controlling person shall have the rights and duties given to each Holder by the preceding paragraph. 

(c) If the indemnification provided for in this Section 8 is unavailable to an indemnified party under Section 8(a) or
(b) hereof (other than by reason of exceptions provided in those Sections) in respect of any losses, claims, damages, liabilities, judgments, actions or expenses referred to therein, then each applicable indemnifying party, in lieu of
indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages, liabilities, judgments, actions or expenses in such proportion as is appropriate to reflect
the relative benefits received by the Company and the Guarantors, on the one hand, and the Holders of the applicable series, on the other hand, from the Initial Placement (which in the case of the Company and the Guarantors shall be deemed to be
equal to the total gross proceeds to the Company and the Guarantors from the Initial Placement), the amount of Additional Interest which did not become payable as a result of the filing of the Registration Statement resulting in such losses, claims,
damages, liabilities, judgments, actions or expenses, and such Registration Statement, or if such allocation is not permitted by applicable law, the relative fault of the Company and the Guarantors, on the one hand, and the Holders of such series,
on the other hand, in connection with the statements or omissions which resulted in such losses, claims, damages, liabilities, judgments, actions or expenses, as well as any other relevant equitable considerations. The relative fault of the Company
on the one hand and of the Indemnified Holder on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company or any of the Guarantors, on the one hand, or the Indemnified Holders, on the other hand, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. The amount paid or payable by a party as a result of the losses, claims, damages, liabilities, judgments, actions and expenses referred to above shall be deemed to include, subject to the limitations set forth in the
second paragraph of Section 8(a) hereof, any legal or other fees or expenses reasonably incurred by such party in connection with investigating or defending any action or claim. 

The Company, the Guarantors and each Holder of Transfer Restricted Securities agree that it would not be just and equitable if
contribution pursuant to this Section 8(c) were determined by pro rata allocation (even if the Holders of the applicable series were treated as one entity for such purpose) or by any other method of allocation which does not take account of the
equitable considerations referred to in the immediately preceding paragraph. The amount paid or payable by an indemnified party as a result of the losses, claims, damages, liabilities, judgments, actions or expenses referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection 

  
 14 








 
with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 8, none of the Holders (and its related Indemnified Holders) shall be required to
contribute, in the aggregate, any amount in excess of the amount by which the total discount received by such Holder with respect to the Securities exceeds the amount of any damages which such Holder has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not
guilty of such fraudulent misrepresentation. The Holders’ obligations to contribute pursuant to this Section 8(c) are several in proportion to the respective principal amount of Securities of the applicable series held by each of the
Holders hereunder and not joint. 
 SECTION 9. Rule 144A. Each of the Company and the Guarantors hereby agrees
with each Holder, for so long as any Transfer Restricted Securities of a series remain outstanding, to make available to any Holder or beneficial owner of Transfer Restricted Securities of such series in connection with any sale thereof and any
prospective purchaser of such Transfer Restricted Securities from such Holder or beneficial owner, the information required by Rule 144A(d)(4) under the Securities Act in order to permit resales of such Transfer Restricted Securities pursuant to
Rule 144A under the Securities Act.  
 SECTION 10. Participation in Underwritten Registrations. No Holder
may participate in any Underwritten Registration hereunder unless such Holder (a) agrees to sell such Holder’s Transfer Restricted Securities on the basis provided in any underwriting arrangements approved by the Persons entitled hereunder
to approve such arrangements and (b) completes and executes all reasonable questionnaires, powers of attorney, indemnities, underwriting agreements, lock-up letters and other documents required under the terms of such underwriting arrangements.
 
 SECTION 11. Selection of Underwriters. The Holders of Transfer Restricted Securities of a series
covered by a Shelf Registration Statement who desire to do so may sell such Transfer Restricted Securities in an Underwritten Offering. In any such Underwritten Offering, the investment banker(s) and managing underwriter(s) that will administer such
offering will be selected by the Holders of a majority in aggregate principal amount of the Transfer Restricted Securities of such series included in such offering; provided, however, that such investment banker(s) and managing underwriter(s) must
be reasonably satisfactory to the Company.  
 SECTION 12. Miscellaneous. 

(a) Remedies. Each of the Company and the Guarantors hereby agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Agreement and hereby agree to waive the defense in any action for specific performance that a remedy at law would be adequate.  

(b) No Inconsistent Agreements. Each of the Company and the Guarantors will not on or after the date of this Agreement
enter into any agreement with respect to its securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. The rights granted to the Holders hereunder do not in any way
conflict with and are not inconsistent with the rights granted to the holders of the Company’s or any of the Guarantors’ securities under any agreement in effect on the date hereof.  

(c) Adjustments Affecting the Securities. The Company will not effect any change, or permit any change to occur, with
respect to the term of the Securities of a series that would materially and adversely affect the ability of the Holders to Consummate any Exchange Offer for such series.  

(d) Amendments and Waivers. The provisions of this Agreement may not be amended, modified or supplemented, and waivers or consents
to or departures from the provisions hereof may not be given unless the Company has (i) in the case of Section 5 hereof and this Section 12(d)(i), obtained the written consent of Holders of all outstanding Transfer Restricted
Securities and (ii) in the case of all other provisions hereof, obtained the written consent of Holders of a majority of the outstanding principal amount of each series of Transfer Restricted Securities affected by the amendment, modification
or supplement, voting as a single class (excluding any Transfer Restricted Securities held by the Company or its Affiliates). Notwithstanding the foregoing, a waiver or consent to departure from the provisions hereof that relates exclusively to the
rights of Holders whose securities are being tendered pursuant to the Exchange Offer and that does not affect directly or indirectly the rights of other Holders whose 

  
 15 








 
securities are not being tendered pursuant to such Exchange Offer may be given by the Holders of a majority of the outstanding principal amount of Transfer Restricted Securities being tendered or
registered; provided, however, that, with respect to any matter that directly or indirectly affects the rights of any Initial Purchaser hereunder, the Company shall obtain the written consent of each such Initial Purchaser with respect to which such
amendment, qualification, supplement, waiver, consent or departure is to be effective. 
 (e) Notices. All notices
and other communications provided for or permitted here under shall be made in writing by hand-delivery, first-class mail (registered or certified, return receipt requested), telex, telecopier, or air courier guaranteeing overnight delivery: 

 (i) if to a Holder, at the address set forth on the records of the Registrar under the Indenture, with a
copy to the Registrar under the Indenture; and 
 (ii) if to the Company or any Guarantor: 

LyondellBasell Industries N.V. 
 Stationsplein 45 
 3013 AK Rotterdam 

The Netherlands 
 Facsimile: +31 10 713 6259 
 Attention: General Counsel 

with a copy to: 
 Lyondell Chemical Company 
 1221 McKinney Street 

Suite 700 
 Houston, TX 77010 
 Facsimile: (713) 309-4631 

Attention: General Counsel 
 All such notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; five Business Days after being deposited in the mail, postage prepaid,
if mailed; when answered back, if telexed; when receipt acknowledged, if telecopied; and on the next Business Day, if timely delivered to an air courier guaranteeing overnight delivery. 

Copies of all such notices, demands or other communications shall be concurrently delivered by the Person giving the same to the Trustee
at the address specified in the Indenture. 
 (f) Successors and Assigns. This Agreement shall inure to the
benefit of and be binding upon the successors and assigns of each of the parties, including, without limitation, and without the need for an express assignment, subsequent Holders of Transfer Restricted Securities; provided, however, that this
Agreement shall not inure to the benefit of or be binding upon a successor or assign of a Holder unless and to the extent such successor or assign acquired Transfer Restricted Securities from such Holder.  

(g) Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.  
 (h) Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.  

(i) Governing Law. THIS AGREEMENT (AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT) SHALL
BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO THE CONFLICTS OF LAW RULES THEREOF.  

  
 16 








 (j) Severability. In the event that any one or more of the provisions
contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions contained herein
shall not be affected or impaired thereby. 
 (k) Entire Agreement. This Agreement is intended by the
parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. There are no restrictions, promises,
warranties or undertakings, other than those set forth or referred to herein with respect to the registration rights granted by the Company with respect to the Transfer Restricted Securities. This Agreement supersedes all prior agreements and
understandings between the parties with respect to such subject matter.  
 [Signature page to follow] 

  
 17 








 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	LyondellBasell Industries N.V.
		
	 By:
	 	 
		 	 Name:

		 	 Title:     Attorney

	
	Guarantors
	LYONDELLBASELL FINANCE COMPANY
	LYONDELLBASELL ACETYLS, LLC
	HOUSTON REFINING LP
	LYONDELLBASELL F&F HOLDCO, LLC
	LYONDELLBASELL ACETYLS HOLDCO, LLC
	LYONDELL REFINING I LLC
	LYONDELL REFINING COMPANY LLC
	LYONDELL EUROPE HOLDINGS INC.
	LYONDELL CHIMIE FRANCE LLC
	LYONDELL CHEMICAL COMPANY
	LYONDELL CHEMICAL TECHNOLOGY, L.P.
	LYONDELL CHEMICAL TECHNOLOGY MANAGEMENT, INC.
	LYONDELL CHEMICAL TECHNOLOGY 1 INC.
	LYONDELL CHEMICAL PROPERTIES, L.P.
	LYONDELL CHEMICAL OVERSEAS SERVICES, INC.
	LYONDELL CHEMICAL INTERNATIONAL COMPANY
	EQUISTAR CHEMICALS, LP
	BASELL NORTH AMERICA INC.
	EQUISTAR GP, LLC
	EQUISTAR LP, LLC


  

			
	
		
	 All By:
	 	 
		 	 Name:

		 	 Title:     Authorized Person




  
 1 







 The foregoing Registration Rights Agreement is hereby confirmed and accepted as of the date
first above written: 
  

			
	 J.P. MORGAN SECURITIES LLC
 Acting on behalf of itself
 and as the Representative of

the several Initial Purchasers

		
	 By:
	 	J.P. Morgan Securities LLC
		
	By:	 	 
		 	 Name:

		 	 Title:     Managing Director




  
 2